Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial.

Tanya N. Turan,Jenifer H. Voeks,Marc I. Chimowitz,Ana Roldan,Todd LeMatty,William Haley,Maria F. Lopes-Virella,Seemant Chaturvedi,Michael R. Jones,Donald Heck,George Howard,Brajesh K. Lal,James F. Meschia,Thomas G. Brott

Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial.

2020

Tanya N. Turan
Jenifer H. Voeks
Marc I. Chimowitz
Ana Roldan
Todd LeMatty
William Haley
Maria F. Lopes-Virella
Seemant Chaturvedi
Michael R. Jones
Donald Heck
George Howard
Brajesh K. Lal
James F. Meschia
Thomas G. Brott

Background and Purpose: The CREST2 trial (Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis) is comparing intensive medical management (IMM) alone to IMM plus revas...

Keywords:

Stent
Stenosis
Cardiology
Asymptomatic
Medicine
Risk factor
carotid revascularization
Internal medicine
Blood pressure

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations